Even Mild Sleep Apnoea Increases Cardiovascular Risk
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Even Mild Sleep Apnoea Increases Cardiovascular Risk

NEW YORK -- October 24, 2008 -- People with even minimally symptomatic obstructive sleep apnoea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study in the November issue of American Journal of Respiratory and Critical Care Medicine.

Their findings suggested that minimally symptomatic OSA is a cardiovascular risk factor to a degree not previously known.

"It was previously known that people with OSA severe enough to affect their daytime alertness and manifest in other ways are at increased risk of cardiovascular disease, but this finding suggests that many more people -- some of whom may be completely unaware that they even have OSA -- are at risk than previously thought," said lead author Malcolm Kohler, MD, Oxford Centre for Respiratory Medicine, Oxford, United Kingdom.

To determine the exact nature of some of these effects, Dr. Kohler and colleagues performed a controlled, cross-sectional study to assess differences in endothelial function, arterial stiffness, and blood pressure in 64 patients with minimally symptomatic OSA. Patients were matched with 15 control subjects without OSA.

"In our study, the augmentation index, was significantly higher in patients with minimally symptomatic OSA compared with matched controls," said Dr. Kohler. "We also found impaired endothelial function as indicated by decreased vascular reactivity of their arteries compared with control subjects without OSA."

The difference in arterial stiffness between OSA patients and control subjects, Dr. Kohler said was "comparable in size to the effect seen after 4 weeks' continuous positive airway pressure (CPAP) therapy in patients with moderate to severe symptomatic OSA."

This suggests that asymptomatic or minimally symptomatic patients with OSA may enjoy a cardiovascular benefit from CPAP therapy.

SOURCE: American Thoracic Society

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities